| Mukherjee D, Patil CG. Epidemiology and the global burden of stroke[J]. World Neurosurg, 2011, 76:S85-S90. 陈竺. 全国第三次死因回顾性抽样调查报告[M]. 北京:中国协和医科大学出版社, 2008 :10-17. 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中国全科医学, 2011, 35:4013-4017. Smadja D. Pharmacological revascularization of acute ischaemic stroke; focus on challenges and novel strategies[J]. CNS Drugs, 2012, 26:309-318. Hassan AE, Chaudhry SA, Grigoryan M, et al. National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era[J]. Stroke, 2012, 43:3012-3017. 王拥军. 主编手记[J]. 中国卒中杂志, 2006, 1:插页. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J]. Lancet, 2010, 375:1695-1703. 奉涛. 溶栓药物的临床应用及其进展[J]. 临床合理用药杂志, 2011, 12:145-146. 吴丹明, 张立魁. 溶栓药物分类及合理应用[J]. 中国实用外科杂志, 2011, 12:1136-1137. No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group[J]. N Engl J Med, 1995, 333:1581-1587. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2008, 359:1317-1329. IST-3 collaborative group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke(the Third International Stroke Trial[IST-3]):a randomised controlled trial[J]. Lancet, 2012, 379:2352-2363. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study(SITS-MOST):an observational study[J]. Lancet, 2007, 369:275-282. Rha JH, Shrivastava VP, Wang Y, et al. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population:results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World(SITS-NEW) [EB/OL]. (2012-09-19)[2013-01-15]. http://onlinelibrary.wiley.com/doi/10.1111/j.1747-4949.2012.00895.x/abstract.com Adams HJ, Del ZG, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke:a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups; the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists[J]. Stroke, 2007, 38:1655-1711. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator[J]. Neurology, 2002, 59:862-867. Zinkstok SM, Roos YB; ARTIS investigators. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke; a randomised controlled trial[J]. Lancet, 2012, 380:731-737. Mullen MT, Pisapia JM, Tilwa S, et al. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis[J]. Stroke, 2012, 43:2350-2355. 董强, 黄家星, 黄一宁, 等. 症状性动脉粥样硬化性颅内动脉狭窄中国专家共识[J]. 中国神经精神疾病杂志, 2012, 3:129-145. Nam HS, Han SW, Lee JY, et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke[J]. Neurology, 2006, 67:1184-1188. Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis:subgroup analyses from WASID[J]. Neurology, 2006, 67:1275-1278. Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment(WingSpan)[J]. Neuroradiology, 2005, 47:222-228. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J]. N Engl J Med, 2011, 365:993-1003 Miao Z, Jiang L, Wu H, et al. Randomized controlled trial of symptomatic middle cerebral artery stenosis:endovascular versus medical therapy in a Chinese population[J]. Stroke, 2012, 43:3284-3290. Jiang WJ, Yu W, Du B, et al. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting[J]. Stroke, 2011, 42:1971-1975. European Stroke Organisation(ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008[J]. Cerebrovasc Dis, 2008, 25:457-507. |
